a Department of Biochemistry , Functional Food and Nutraceutical Unit, Federal University of Technology , Akure , Nigeria.
b Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria , Santa Maria , Brazil.
Redox Rep. 2017 Nov;22(6):563-571. doi: 10.1080/13510002.2017.1344013. Epub 2017 Jun 28.
This study investigated the potential anti-inflammatory effect of hesperidin against carrageenan induced pleurisy in rat model.
Twenty-four adult female Wistar rats (350 - 450g) were grouped as follows: Group I: rats were administered saline solution only (Normal control group); Group II: rats were administered saline solution (NaCl 0.9%) orally and injected with carrageenan (Inflammation control group); Group III: rats were administered hesperidin only (Hesperidin group); Group IV: rats were administered hesperidin orally and intrapleurally injected with 2% carrageenan (Inflammation treated with hesperidin group). The exudate volume, total leukocyte count, reactive oxygen species (ROS), myeloperoxidase (MPO),δ-aminolevulinate dehydratase (δ-ALA-D), catalase (CAT), superoxide dismutase (SOD), activities as well as non-protein thiol group (NPSH) and thiobarbituric acid reactive substances (TBARS) levels were determined.
Pretreatment with hesperidin at a dose of 80 mg/kg orally per day for 21 days, minimized the increase in pleural exudate volume and leucocyte count and modulated the activities of MPO, SOD and CAT, as well as the levels of ROS, NPSH and TBARS in carrageenan-induced rats.
Our results suggest that hesperidin can elicit its anti-inflammatory action by blocking exudate and leukocyte influx into pleural cavity, inhibiting MPO activity and preventing oxidative damage.
本研究旨在探讨橙皮苷对大鼠角叉菜胶性胸膜炎的潜在抗炎作用。
将 24 只成年雌性 Wistar 大鼠(350-450g)分为以下几组:组 I:仅给予生理盐水(正常对照组);组 II:给予生理盐水(0.9%NaCl)口服并注射角叉菜胶(炎症对照组);组 III:给予橙皮苷(橙皮苷组);组 IV:给予橙皮苷口服并胸腔内注射 2%角叉菜胶(用橙皮苷治疗炎症组)。测定渗出液量、总白细胞计数、活性氧(ROS)、髓过氧化物酶(MPO)、δ-氨基酮戊酸脱水酶(δ-ALA-D)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)活性以及非蛋白巯基(NPSH)和硫代巴比妥酸反应物质(TBARS)水平。
每天口服 80mg/kg 橙皮苷预处理 21 天,可最大限度地减少胸腔渗出液量和白细胞计数的增加,并调节 MPO、SOD 和 CAT 的活性,以及角叉菜胶诱导大鼠的 ROS、NPSH 和 TBARS 水平。
我们的结果表明,橙皮苷通过阻断渗出物和白细胞流入胸腔、抑制 MPO 活性和防止氧化损伤来发挥其抗炎作用。